Aster Capital Management’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
Aster Capital Management's PVLA Position: Q3 2026 in Review
Aster Capital Management opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 46 shares worth $6.34K. The stake represents ﹤0.01% of the portfolio and ranks #817 among its holdings.
199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- Aster Capital Management held 46 shares of Palvella Therapeutics worth $6.34K as of Q3 2026.
- Palvella Therapeutics was a new Aster Capital Management position in Q3 2026.
- Palvella Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #817 holding.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.